Reducing serious infections and overdoses in people who inject drugs
Strategies to reduce serious bacterial infections and overdose among people who inject drugs
This study is looking for better ways to help people who inject drugs by finding out how to reduce the chances of serious infections and overdoses, so we can improve their health and safety in the long run.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10846815 on NIH RePORTER |
What this research studies
This research investigates ways to lower the risk of serious bacterial infections and overdoses among individuals who inject drugs. It focuses on understanding the long-term effects of different interventions and practices related to opioid use. By using simulation modeling, the study aims to project the outcomes and costs associated with these interventions, providing insights into how to improve health outcomes for this population. The research addresses the urgent need for effective strategies in light of the growing opioid epidemic.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are at risk for serious bacterial infections or overdose.
Not a fit: Patients who do not inject drugs or are not at risk for opioid-related complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced rates of serious infections and overdoses for people who inject drugs.
How similar studies have performed: Other research has shown promise in using simulation modeling to address public health issues, indicating that this approach could be effective.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Barocas, Joshua Adam — University of Colorado Denver
- Study coordinator: Barocas, Joshua Adam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.